CooleyยทPHARMA / BIOTECH

Treasury's Proposed COINS Rule Could Reshape China-to-West Biotech NewCo Terms

Cooley reports a proposed US Treasury rule could limit Chinese licensor equity in NewCo vehicles, altering equity-vs-contractual-return terms in China-to-West biotech transactions.

treasury-coins-ruleoutbound-investmentchina-biotech-licensingnewco-structurescross-border-deal-terms
Read the original firm alert โ†’ Wednesday, November 4, 2026

Stay ahead

Join the digest.

Each weekday's issue by email, through Substack. Or follow the RSS feed.